PharmaShots Weekly Snapshots (June 03 – June 07, 2024)
This week PharmaShots’ news was all about the updates on M&A, Pharma, Clinical Trials, Regulatory & MedTech. Check out our full report below:
GSK Highlights P-III (DREAMM-8) Study Data of Blenrep Plus Pomalidomide and Dexamethasone for R/R Multiple Myeloma at ASCO 2024
Read More: GSK
Eli Lilly Highlights the P-I/II Trial Data of Olomorasib for Treating Advanced Solid Tumors at ASCO 2024
Read More: Eli Lilly
Pfizer Reports the P-III (ECHELON-3) Trial Results of Adcetris for Treating R/R Diffuse Large B-cell Lymphoma (DLBCL)
Read More: Pfizer
Sanofi Highlights the P-III (IMROZ) Study Data of Sarclisa for Newly Diagnosed Transplant-Ineligible Multiple Myeloma
Read More: Sanofi
BMS Highlights Data from three P-III Studies of Breyanzi to Treat Various B-Cell Malignancies at ASCO 2024
Read More: BMS
BMS Features the P-III (CheckMate -9DW) Trial Data of Opdivo Plus Yervoy for Treating Advanced Hepatocellular Carcinoma at ASCO 2024
Read More: BMS
The USPTO Issues Notice of Allowance for New Patent Covering MediciNova’s Ibudilast (MN-166) to Prevent Metastasis of Multiple Solid Tumors
Read More: MediciNova
Gilead Reports Data from the P-III (ASSURE) Trial of Seladelpar for Treating Primary Biliary Cholangitis
Read More: Gilead
AbbVie Reports Advancement of ABBV-383 to P-III Study for the Treatment of Multiple Myeloma
Read More: AbbVie
Amgen Reports the P-III (MITIGATE) Study Data of Uplizna (Inebilizumab-cdon) to Treat Immunoglobulin G4-Related Disease (IgG4-RD)
Read More: Amgen
AbbVie Reports the P-II (PICCOLO) Study Data of Elahere (Mirvetuximab Soravtansine) for Treating Ovarian Cancer
Read More: AbbVie
Boehringer Ingelheim Reports Additional Data from the P-II Study of Survodutide to Treat Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Read More: Boehringer Ingelheim
AstraZeneca’s Tagrisso Receives the CHMP’s Positive Opinion for Treating EGFR-Mutated advanced Lung Cancer
Read More: AstraZeneca
CStone Pharmaceuticals’ Cejemly Receives the CHMP’s Positive Opinion for Treating NSCLC
Read More: CStone Pharmaceuticals
NeoImmuneTech’s Efineptakin Alfa (NT-I7) Receives the EMA’s Orphan Drug Designation to Treat Acute Radiation Syndrome
Read More: NeoImmuneTech
Saghmos Therapeutics Receives the US Patent for ST-62516 to Reduce the Risk of Acute Kidney Injury
Read More: Saghmos Therapeutics
Geron’s Rytelo (Imetelstat) Gains the US FDA’s Approval to Treat Myelodysplastic Syndromes (MDS) with Transfusion-Dependent Anemia
Read More: Geron
Immutep Partners with Merck to Conduct P-III Study of Eftilagimod Alfa (Efti) with Keytruda for Treating NSCLC
Read More: Immutep & Merck
FibroGen Collaborates with Regeneron to Assess FG-3165 and FG-3175 Plus Libtayo for Treating Solid Tumors
Read More: FibroGen & Regeneron
BlueSphere Bio and the National Cancer Institute Team Up to Develop Therapies for Rare Respiratory Disease
Read More: BlueSphere Bio & National Cancer Institute
ArriVent BioPharma Collaborates with Alphamab to Develop Antibody Drug Conjugates for Treating Cancers
Read More: ArriVent BioPharma & Alphamab
HighLife’s TSMVR System Obtains the US FDA’s IDE Approval to Commence Clinical Trial for Treating Mitral Regurgitation
Read More: HighLife
Evolution Optiks Gains the US FDA’s 510(k) Clearance for Eye Examination Device
Read More: Evolution Optiks
The US FDA Grants Clearance to Moon Surgical’s Commercial Maestro Robotic Surgery System
Read More: Moon Surgical
Abbott’s AVEIR Dual Chamber Leadless Pacemaker System Gains CE Mark to Treat Abnormal or Slow Heart Rhythms
Read More: Abbott
Stryker Acquires Artelon, Enhancing its Portfolio of Soft Tissue Fixation Solutions
Read More: Stryker & Artelon
BD Reports the Acquisition of Edwards Lifesciences' Critical Care Product Group, Enhancing its Smart Connected Care Solutions
Read More: BD & Edwards Lifesciences
GSK Acquires Elsie Biotechnologies to Advance Oligonucleotide Platform and Pipeline Therapies
Read More: GSK & Elsie Biotechnologies
Ventyx Biosciences Reports Preclinical Data of VTX3232 in Murine Diet-Induced Obesity Models
Read More: Ventyx Biosciences
Zomedica Highlights the Data of TRUFORMA Research to Diagnose Thyroid Disease in Cats at ACVIM 2024
Read More: Zomedica
Related Post: PharmaShots Weekly Snapshots (May 27 – May 31, 2024)
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
